Literature DB >> 19714567

Transgenic expression of human wild-type amyloid precursor protein decreases neurogenesis in the adult hippocampus.

Nicole Naumann1, Alán Alpár, Uwe Ueberham, Thomas Arendt, Ulrich Gärtner.   

Abstract

Besides its role in Alzheimer's disease, the amyloid precursor protein (APP) is implicated in several physiological functions in neuronal tissue such as cell survival, neurite outgrowth, synaptic formation, and neuronal plasticity. The present study analyzed effects of human wild-type APP (hAPP) overexpression on adult hippocampal neurogenesis in transgenic mice. Mice were housed under either standard or enriched conditions, the latter to boost neurogenetic activity. Different aspects of neurogenesis including proliferation, survival, and differentiation were assessed by employing the BrdU-incorporation method and, in parallel, immunohistochemistry for the neuronal and glial markers NeuN and S100b, respectively. Overexpression of hAPP caused a significant decrease in cell proliferation under standard housing conditions. The relative increase in the proliferation rate following housing in enriched environment was not different to that observed in wild-type mice. Overexpression of hAPP, on the other hand, promoted the survival of newly generated cells, but just under conditions of standard housing. Findings further suggest that overexpression of hAPP suppresses the phenotypic shift toward neuronal differentiation under conditions of enriched environment. In summary, the results reveal a dual effect of APP on adult hippocampal neurogenesis, comprising antiproliferative and prosurvival activities. Copyright 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19714567     DOI: 10.1002/hipo.20693

Source DB:  PubMed          Journal:  Hippocampus        ISSN: 1050-9631            Impact factor:   3.899


  15 in total

1.  Adult human neurogenesis: from microscopy to magnetic resonance imaging.

Authors:  Amanda Sierra; Juan M Encinas; Mirjana Maletic-Savatic
Journal:  Front Neurosci       Date:  2011-04-04       Impact factor: 4.677

Review 2.  The upside of APP at synapses.

Authors:  Hyang-Sook Hoe; Hey-Kyoung Lee; Daniel T S Pak
Journal:  CNS Neurosci Ther       Date:  2010-12-27       Impact factor: 5.243

3.  CD2-associated protein (CD2AP) overexpression accelerates amyloid precursor protein (APP) transfer from early endosomes to the lysosomal degradation pathway.

Authors:  Kotaro Furusawa; Toshiyuki Takasugi; Yung-Wen Chiu; Yukiko Hori; Taisuke Tomita; Mitsunori Fukuda; Shin-Ichi Hisanaga
Journal:  J Biol Chem       Date:  2019-05-28       Impact factor: 5.157

Review 4.  Cognitive reserve and Alzheimer's disease.

Authors:  Wei Xu; Jin-Tai Yu; Meng-Shan Tan; Lan Tan
Journal:  Mol Neurobiol       Date:  2014-05-04       Impact factor: 5.590

5.  Phosphorylation of amyloid precursor protein at threonine 668 is essential for its copper-responsive trafficking in SH-SY5Y neuroblastoma cells.

Authors:  Karla M Acevedo; Carlos M Opazo; David Norrish; Leesa M Challis; Qiao-Xin Li; Anthony R White; Ashley I Bush; James Camakaris
Journal:  J Biol Chem       Date:  2014-03-07       Impact factor: 5.157

6.  Combination therapy prevents amyloid-dependent and -independent structural changes.

Authors:  Gauri Malthankar-Phatak; Shane Poplawski; Nikhil Toraskar; Robert Siman
Journal:  Neurobiol Aging       Date:  2011-01-22       Impact factor: 4.673

Review 7.  Altered neurogenesis in mouse models of Alzheimer disease.

Authors:  Oliver Wirths
Journal:  Neurogenesis (Austin)       Date:  2017-05-09

8.  Biology and pathophysiology of the amyloid precursor protein.

Authors:  Hui Zheng; Edward H Koo
Journal:  Mol Neurodegener       Date:  2011-04-28       Impact factor: 14.195

9.  All in the Family: How the APPs Regulate Neurogenesis.

Authors:  Orly Lazarov; Michael P Demars
Journal:  Front Neurosci       Date:  2012-06-04       Impact factor: 4.677

Review 10.  Insights into the physiological function of the β-amyloid precursor protein: beyond Alzheimer's disease.

Authors:  Edgar Dawkins; David H Small
Journal:  J Neurochem       Date:  2014-03-07       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.